Pharsight

Drugs that contain Abiraterone Acetate

1. Yonsa patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9889144 SUN PHARM Abiraterone acetate formulation and methods of use
Mar, 2034

(10 years from now)

US10292990 SUN PHARM Abiraterone steroid formulation
May, 2034

(10 years from now)

Market Authorisation Date: 22 May, 2018

Treatment: Use in combination with methylprednisolone for the treatment of patients with prostate cancer

Dosage: TABLET;ORAL

How can I launch a generic of YONSA before it's drug patent expiration?
More Information on Dosage

YONSA family patents

Family Patents